Company / Current Assets
Phio Pharmaceuticals Corp. Current Assets History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$15.2M
FY2020
5-year range
$3.8M / $15.2M
FY2016-FY2020
Trend
+107.7%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 7 years, ranging from $4M in FY2017 to $15M in FY2020.
Based on SEC 10-K filings.
$15M in FY2020 with a 3-year CAGR of +58.2%.
Remained stable around $15M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +58.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +58.2%, indicating consistent growth.
- In FY2020, current assets increased 107.7% year-over-year.
- Lowest current assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $15.2M | +107.7% |
| FY2019 | $7.3M | -51.8% |
| FY2018 | $15.2M | +295.4% |
| FY2017 | $3.8M | -70.8% |
| FY2016 | $13.1M | -11.1% |
| FY2013 | $14.7M | +173.4% |
| FY2012 | $5.4M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026